Clinical development of innovative therapeutic solutions for the canine and feline veterinary market: oncology and chronic diseases
Vetbiolix has raised $4.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Vetbiolix's investors include Bpifrance, Tudigo, Captech Santé, Nord France Amorcage.
Vetbiolix is headquartered in Loos, France.
Clinical development of innovative therapeutic solutions for the canine and feline veterinary market: oncology and chronic diseases
Vetbiolix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vetbiolix — Funding & Investors." VCBacked, December 6, 2024, https://www.vcbacked.co/company/vetbiolix. Accessed September 30, 2026.
VCBacked. (2024). Vetbiolix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vetbiolix
{{cite web |title=Vetbiolix — Funding & Investors |url=https://www.vcbacked.co/company/vetbiolix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated